Cargando…

Cost-benefit of COVID-19 lockdown in the UK

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441139/
https://www.ncbi.nlm.nih.gov/pubmed/32843836
http://dx.doi.org/10.1007/s40274-020-7058-0
_version_ 1783573245735206912
collection PubMed
description
format Online
Article
Text
id pubmed-7441139
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74411392020-08-21 Cost-benefit of COVID-19 lockdown in the UK PharmacoEcon Outcomes News Clinical Study Springer International Publishing 2020-08-22 2020 /pmc/articles/PMC7441139/ /pubmed/32843836 http://dx.doi.org/10.1007/s40274-020-7058-0 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Cost-benefit of COVID-19 lockdown in the UK
title Cost-benefit of COVID-19 lockdown in the UK
title_full Cost-benefit of COVID-19 lockdown in the UK
title_fullStr Cost-benefit of COVID-19 lockdown in the UK
title_full_unstemmed Cost-benefit of COVID-19 lockdown in the UK
title_short Cost-benefit of COVID-19 lockdown in the UK
title_sort cost-benefit of covid-19 lockdown in the uk
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441139/
https://www.ncbi.nlm.nih.gov/pubmed/32843836
http://dx.doi.org/10.1007/s40274-020-7058-0